+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Protective effect of monophosphoryl lipid A during systemic candidiasis in neutropenic and normal mice



Protective effect of monophosphoryl lipid A during systemic candidiasis in neutropenic and normal mice



Surgical Forum 45: 50-52




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 033004532

Download citation: RISBibTeXText


Related references

Combined effect of fluconazole and recombinant human interleukin-1 on systemic candidiasis in neutropenic mice. Antimicrobial Agents and ChemoTherapy 36(6): 1225-1229, 1992

Evaluation of protective effect of recombinant dense granule antigens GRA2 and GRA6 formulated in monophosphoryl lipid A (MPL) adjuvant against Toxoplasma chronic infection in mice. Vaccine 25(21): 4301-4311, 2007

PCR-monitoring of response to Ambisome treatment of systemic candidiasis in neutropenic mice. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 35: 38, 1995

Improved detection of Candida albicans by PCR in blood of neutropenic mice with systemic candidiasis. Journal of Clinical Microbiology 33(3): 625-628, 1995

PCR monitoring of response to liposomal amphotericin B treatment of systemic candidiasis in neutropenic mice. Journal of Clinical Microbiology 34(1): 25-28, 1996

Polymeric carriers for amphotericin B: in vitro activity, toxicity and therapeutic efficacy against systemic candidiasis in neutropenic mice. Journal of Antimicrobial ChemoTherapy 52(3): 419-427, 2003

Immunogenicity and protective capacity of a virosomal respiratory syncytial virus vaccine adjuvanted with monophosphoryl lipid A in mice. Plos one 7(5): E36812, 2012

Enhancement of influenza a virus protective immunity in mice using monophosphoryl lipid a and trehalose dimycolate as vaccine adjuvants. FASEB Journal 2(4): ABSTRACT 3118, 1988

Studies on defence effects of recombinant human granulocyte colony-stimulating factor (G-CSF) to infections. III. Protective effect on pulmonary and systemic infections of P. aeruginosa in neutropenic mice. Kansenshogaku Zasshi. Journal of the Japanese Association for Infectious Diseases 64(5): 604-611, 1990

Effect of biological response modifiers against pulmonary candidiasis in neutropenic mice. Kansenshogaku Zasshi. Journal of the Japanese Association for Infectious Diseases 68(4): 513-519, 1994

Anti-enolase antibodies partially protective against systemic candidiasis in mice. Clinical Microbiology and Infection 2(1): 36-43, 1996

Intratumoral delivery of low doses of anti-CD40 mAb combined with monophosphoryl lipid a induces local and systemic antitumor effects in immunocompetent and T cell-deficient mice. Journal of ImmunoTherapy 36(1): 29-40, 2013

B cell knockout mice are resistant to mucosal and systemic candidiasis of endogenous origin but susceptible to experimental systemic candidiasis. Journal of Infectious Diseases 174(3): 589-597, 1996

Protective effect of glucan against systemic Staphylococcus aureus septicemia in normal and leukemic mice. Infection and Immunity 20(3): 804-810, 1978

Therapeutic effect of monophosphoryl lipid A administration on Paracoccidioides brasiliensis-infected mice. Medical Mycology 55(3): 344-348, 2017